Home > News > BioSante Pharmaceuticals Signs Option and License
February 27th, 2006
BioSante Pharmaceuticals Signs Option and License
Abstract:
BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced that it has signed an exclusive option and license agreement with Medical Aesthetics Technology Corporation ("MATC") for the use of BioSante's calcium phosphate nanotechnology (CaP) in the field of aesthetic medicine.
Source:
businesswire
Bookmark:
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Materials
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
Weird science: Crystals melt when they're cooled May 22nd, 2013
INSCX™ exchange announces substantial increase in capital designated to provide Trade Finance for registered Nanomaterial Producers May 21st, 2013
Announcements
How do cold ions slide May 24th, 2013
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013